Percutaneous Coronary Intervention Clinical Trial
Official title:
Plaque mOrphology iMpact on Side Branch Occlusion at oPtical Coherence Tomography Evaluation in Percutaneous Coronary Interventions: The POMPEI Study
Despite recent advances in interventional cardiology, bifurcation coronary artery stenoses
(which account for 15-20% of all coronary lesions treated by PCI), remain a challenge for PCI
operators with higher rates of failure, in-stent restenosis, stent thrombosis, and recurrent
clinical events, when compared to simple non-bifurcation lesions.
POMPEI trial is a prospective observational study. We aim to investigate the impact of
morphological plaque characteristics assessed by optical coherence tomography (OCT) on the
risk of developing side branch occlusion (SBO) in bifurcation PCI.
A total of 27 patients undergoing bifurcation PCI will be recruited into the trial. PCI will
be performed according to local practice.The bifurcation lesion will be imaged by OCT on at
least two time-points for each patient. Plaque morphology will be characterized by OCT.
Off-line quantitative coronary angiography (QCA) will be performed before and after PCI and
the following QCA parameters will be computed: reference vessel diameter (RVD), lesion length
and diameter stenosis (DS) of Main Vessel (MV) and side branch (SB). Blood samples will be
taken prior to PCI and 8-12 hours later to determine peri-procedural myocardial injury and
infarction following PCI by measuring serum Troponin. The OCT data analysis will be performed
in collaboration with Dr Valeria Paradies who has been trained in interventional cardiology
in Rotterdam (The Netherlands) with specific interest in intravascular imaging.
In conclusion, we will use OCT to detect specific morphological characteristics which are
associated with acute SBO following main vessel stenting. The routine use of OCT during
bifurcation PCI to detect those patients at risk of acute SBO following main vessel stenting
will allow the PCI operator to implement measures for reducing the risk of SBO, thereby
minimizing the risk of peri- and post-PCI angina, preventing peri-procedural myocardial
injury and infarction, and improving clinical outcomes.
We hypothesized that in bifurcation lesion treatment, morphology of the plaque located in the
main vessel may impact on the risk of developing SBO.
The objectives of POMPEI study as follows:
Primary objective:
To identify correlation between lipid volume content of MV plaque and risk of SBO (TIMI
flow<3)
Secondary objectives:
To identify the plaque morphology characteristics associated with SBO in patients undergoing
bifurcation PCI. OCT parameters which will be assessed include: distribution of lipid volume
and lipid arc in the MV and around SB ostium before and after stenting; prevalence of healed
plaque rupture and erosion and its correlation with SBO; correlation between calcium
distribution within the plaque and SBO; correlation between bifurcation angle and SBO; and
correlation between angiographic images of haziness at SB ostium and OCT findings.
To determine the prevalence of significant SB ostium stenosis in patients undergoing
bifurcation PCI.
To determine the incidences of SBO following bifurcation PCI.
To determine the incidence and extent of peri-procedural myocardial injury and infarction
following bifurcation PCI.
To determine correlation between SB lesion extension from the ostium and SBO
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
| Not yet recruiting |
NCT05669222 -
The FAVOR V AMI Trial
|
N/A | |
| Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
| Recruiting |
NCT05240781 -
Zotarolimus vs Sirolimus Eluting Stent in High Bleeding Risk
|
N/A | |
| Recruiting |
NCT03378934 -
Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention
|
Phase 4 | |
| Not yet recruiting |
NCT06025071 -
Residual Inflammatory Risk-Guided colcHicine in Elderly Trial
|
Phase 4 | |
| Withdrawn |
NCT04043091 -
Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction
|
N/A | |
| Completed |
NCT03085823 -
The All-comers Sirolimus-coated Balloon European Registry
|
||
| Completed |
NCT02837744 -
Studying Hemostatic Effect of Axiostat® Dressing on Radial Access After Percutaneous Procedure
|
||
| Completed |
NCT02044146 -
A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk
|
Phase 2/Phase 3 | |
| Completed |
NCT03131271 -
Effect of Ice Bag Application to Femoral Region on Pain in Patients Undergoing Percutaneous Coronary Intervention
|
N/A | |
| Completed |
NCT01135667 -
Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI
|
Phase 4 | |
| Completed |
NCT01156571 -
A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention (PCI) (CHAMPION PHOENIX)
|
Phase 3 | |
| Unknown status |
NCT00751491 -
Clopidogrel Versus Adenosin in Non Urgent Percutaneous Coronary Intervention (PCI)
|
Phase 3 | |
| Completed |
NCT00725868 -
Blood Endothelium Biomarkers to Predict Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention
|
N/A | |
| Completed |
NCT03708588 -
Chewed Versus Integral Pill of Ticagrelor
|
Phase 4 | |
| Completed |
NCT04163393 -
R-One Efficiency For PCI Evolution With Robotic Assistance
|
N/A | |
| Recruiting |
NCT05554588 -
Intrathrombus Thrombolysis Versus Aspiration Thrombectomy During Primary PCI
|
N/A | |
| Recruiting |
NCT06080919 -
Plaque Modification And Impact On Microcirculatory Territory After Drug-Coated Balloon Percutaneous Coronary Intervention (PLAMI).
|
N/A | |
| Recruiting |
NCT05353140 -
LAAO Versus NOAC in Patients With AF and PCI
|
N/A |